Merck KGaA, Darmstadt, Germany recently invited leading representatives from the semiconductor industry to Darmstadt to come together and discuss the role ...

NHS England has agreed to reimburse Vertex's newest cystic fibrosis medicine. Meanwhile, Merck advanced its once-monthly PrEP ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has launched the AAW Automated ...

MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology ...

BURLINGTON - MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, confirmed Neoclease as the winner of the 2025 North ...

BioNTech SE's turn toward oncology treatments has the potential to tap multi-billion-dollar markets in the future. Find out ...

Furtado is responsible for shaping and executing an integrated communications strategy across the Gulf region in her new role ...

The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds ...

Stocks are opening higher on Wall Street as the Trump administration seeks to win more deals with global trading partners. The S&P 500 index was up 0.5% in the first few minutes of trading Wednesday.

Global markets have been seesawing this week, as traders digest the latest trade tariff news. Overnight, Asia-Pacific markets ...

German pharmaceutical giant Merck has completed a €3 billion ($3.5 billion) takeover of US biopharmaceutical company Springworks Therapeutics, the firm confirmed on Tuesday. With the acquisition, ...